{
    "2018-04-11": [
        [
            {
                "time": "2018-04-11",
                "original_text": "Novartis’s Valuation and Analysts’ Recommendations on April 11",
                "features": {
                    "keywords": [
                        "Novartis",
                        "valuation",
                        "analysts",
                        "recommendations"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-01",
                "original_text": "Incyte Expected to Report Robust Revenue Growth in Fiscal 2018",
                "features": {
                    "keywords": [
                        "Incyte",
                        "revenue growth",
                        "fiscal 2018"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-01",
                "original_text": "Is Beaten-Down Incyte Corporation Stock a Buy Now?",
                "features": {
                    "keywords": [
                        "beaten-down",
                        "Incyte Corporation",
                        "buy"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-01-01",
                "original_text": "A Look at Eli Lilly’s 1Q18 Stock Performance",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "1Q18",
                        "stock performance"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}